Arabesque Asset Management LTD Axsome Therapeutics, Inc. Transaction History

Arabesque Asset Management LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $545,863 - $712,232	-8,232 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $1.34 Million - $1.69 Million	-19,668 Reduced 70.49%	8,232 $587,000
Q2 2020 Oct 22, 2020	BUY	$49.87 - $98.69 $1.39 Million - $2.75 Million	27,900 New	27,900 $2.3 Million

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Arabesque Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Arabesque Asset Management LTD with notifications on news.